Clincosm LogoSign in Get a demo

Castration Levels of Testosterone

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Detroit,

Active, not recruiting
  • Castration Levels of Testosterone
  • +4 more
  • Detroit, Michigan
  • +1 more
Aug 30, 2022

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory

Active, not recruiting
Has Results
  • Castration Levels of Testosterone
  • +9 more
  • Recombinant EphB4-HSA Fusion Protein
  • Los Angeles, California
  • +2 more
Apr 4, 2022

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in San Francisco

Active, not recruiting
  • Castration Levels of Testosterone
  • +6 more
  • Lutetium Lu 177-PSMA-617
  • Pembrolizumab
  • San Francisco, California
    University of California, San Francisco
Apr 11, 2022

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston,

Active, not recruiting
  • Castration Levels of Testosterone
  • +4 more
  • Abiraterone Acetate
  • +6 more
  • Houston, Texas
  • +2 more
Feb 11, 2022

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma in the Soft Tissue

Recruiting
  • Castration Levels of Testosterone
  • +4 more
  • Abiraterone Acetate
  • +6 more
  • Fairbanks, Alaska
  • +671 more
Dec 29, 2021

Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Mexico, United

Recruiting
  • Castration Levels of Testosterone
  • +4 more
  • Gilbert, Arizona
  • +301 more
Nov 8, 2021

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, PSA Progression Trial in San Francisco (Apalutamide,

Recruiting
  • Castration Levels of Testosterone
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Aug 26, 2021

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Lymphadenopathy Trial in Detroit, Houston

Completed
Has Results
  • Castration Levels of Testosterone
  • +6 more
  • Detroit, Michigan
  • +1 more
Jul 29, 2021

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma in the Soft Tissue

Withdrawn
  • Castration Levels of Testosterone
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 31, 2021

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone Trial in

Recruiting
  • Castration Levels of Testosterone
  • +4 more
  • HER2Bi-Armed Activated T Cells
  • +2 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Feb 26, 2021

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Ann Arbor,

Recruiting
  • Castration Levels of Testosterone
  • +4 more
  • Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981
  • Nivolumab
  • Ann Arbor, Michigan
  • +1 more
Oct 4, 2020

Drug Resistance in Metastatic Castration-Resistant Prostate

Completed
  • Castration Levels of Testosterone
  • +5 more
  • Cytology Specimen Collection Procedure
  • +2 more
  • Los Angeles, California
  • +2 more
Sep 24, 2020

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in United States

Completed
Has Results
  • Castration Levels of Testosterone
  • +3 more
  • Glycosylated Recombinant Human Interleukin-7
  • Laboratory Biomarker Analysis
  • La Jolla, California
  • +15 more
Jun 25, 2019

Castration Levels of Testosterone, Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma in the Soft Tissue Trial in

Terminated
Has Results
  • Castration Levels of Testosterone
  • +5 more
  • San Francisco, California
    University of California, San Francisco
May 29, 2018

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Seattle

Completed
  • Castration Levels of Testosterone
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Apr 16, 2018

Castration Levels of Testosterone, Hormone-Resistant Prostate Cancer, Microsatellite Instability Trial in Seattle (Durvalumab,

Withdrawn
  • Castration Levels of Testosterone
  • +2 more
  • Durvalumab
  • Laboratory Biomarker Analysis
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 12, 2018